Intraday Info: Transgenomic Inc (NASDAQ:TBIO) locked on 29/12/2016 at $0.290s. It has average volume 1.14 million whilst it totals volume 3.68M. And it total income 9.40 million.
Ownership Summary: Transgenomic Inc has total institutional ownership 34.83% while its total outstanding shares 25 millions that’s value of holdings $2 million.
Active Positions: In the latest year, TBIO 9 holders have raised its positions while it contains total 306,897 shares. And the strength of reduced positions holders and held positions holders are 6 and 9 respectively.
New and Sold Out Positions: In TBIO force of new positions holders 5 and it has total shares 191,033. And force of sold out positions holders 1 and it has 11,504 shares.
Comparison with Other Company: The Market Value of TBIO is $7,188 below from Waters Corporation market value which is $10M. Current Last Sale of TBIO is $0.29 below from WAT current last sale which is $134.5.
Transgenomic, Inc. provides genetic analytical laboratory services related to oncology and pharmacogenomics research offerings helping segment II and phase III medical trials performed through pharmaceutical and biotechnology organizations. It employs various genomic checking out carrier technology, counting ICE bloodless-PCR, a proprietary platform generation that enables detection of a couple of known and unknown mutations from really any sample kind, counting tissue biopsies, blood, urine, saliva, mobile-free DNA, and circulating tumor cells. The organization turned into based in 1997 and is situated in Omaha, Nebraska.